Straumann Holding AG EBITDA Margin 2012-2024 | SAUHY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Straumann Holding AG (SAUHY) over the last 10 years. The current EBITDA margin for Straumann Holding AG as of December 31, 2024 is .
Straumann Holding AG EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.857B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.805B 21.44
Becton Dickinson (BDX) United States $51.260B 12.69
Cardinal Health (CAH) United States $38.083B 19.94
West Pharmaceutical Services (WST) United States $15.151B 31.76
Cooper (COO) United States $14.525B 18.72
Align Technology (ALGN) United States $13.828B 27.45
Henry Schein (HSIC) United States $8.411B 14.43
Merit Medical Systems (MMSI) United States $4.906B 23.72
DENTSPLY SIRONA (XRAY) United States $3.125B 9.33
CONMED (CNMD) United States $1.474B 11.03
STAAR Surgical (STAA) United States $0.860B 0.00
Lifevantage (LFVN) United States $0.163B 16.84
Pro-Dex (PDEX) United States $0.151B 16.50